Analyst on US Coloplast contract: Important contract – volumes will probably increase
It's incredibly important for Coloplast that the medtech company has landed a deal to sell ostomy products by way of the largest group purchasing organization in the US, Vizient, according to senior equity analyst. He expects the new contract will lead to increased volumes in the long term.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
The purchasing contract that Coloplast has entered into with the largest group purchasing organization (GPO) in the US, Vizient, is highly significant.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Moment of truth for Coloplast's US venture
For subscribers
Coloplast gets crucial US deal for ostomy product
For subscribers
.jpg&w=384&q=75)
